title: [Research progress on 18F-FDG PET/CT in evaluating prognosis of patient with diffuse large B cell lymphoma].
abstract: Diffuse large B cell lymphoma (DLBCL) is one of the most common pathological type of non Hodgkin's lymphoma in adult, with a high mortality and a variety of prognostic factors. (18)F-FDG PET/CT, a functional imaging modality used for staging and monitoring response of a variety of human neoplasia to treatment, has a higher sensitivity and specificity than conventional anatomical imaging. Patinets taking (18)F-FDG PET/CT scanning for DLBCL before treatment and after complete standard treatment of DLBCL patients not only contributes to the clinical accurate staging, but also has a certain value in evaluating the prognosis of DLBCL patients and monitoring of recurrence. However, the value of interim PET/CT for evaluation of prognosis remains controversial. Therefore, this review focuses on the research progress of (18)F-FDG PET/CT for evaluating prognosis of patient with DLBCL, including baseline, interim and post-treatment (18)F-FDG PET/CT.
authors: Department of Hematology, Chinese PLA General Hospital , Beijing 100853, China.
authors: Yan
authors: Y
authors: Yang
authors: Department of Hematology, Chinese PLA General Hospital , Beijing 100853, China. E-mail: HYZHU1975@163.com.
authors: Hai-Yan
authors: HY
authors: Zhu
authors: Department of Hematology, Chinese PLA General Hospital , Beijing 100853, China.
authors: Li
authors: L
authors: Yu
mesh_terms: D019788:Fluorodeoxyglucose F18; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse; D064847:Multimodal Imaging; D049268:Positron-Emission Tomography; D011379:Prognosis; D014057:Tomography, X-Ray Computed
chemical_list: D019788:Fluorodeoxyglucose F18